Literature DB >> 27207466

Circadian disturbance and idiopathic central serous chorioretinopathy.

Elodie Setrouk1, Beatrice Hubault1, Frédérique Vankemmel2, Olivia Zambrowski1, Pierre Nazeyrollas3, Brigitte Delemer4,3, Vincent Durlach3, Alain Ducasse1, Carl Arndt5.   

Abstract

BACKGROUND: This present retrospective case control study was designed to evaluate circadian disturbance in patients with chronic idiopathic central serous chorioretinopathy (ICSC).
METHODS: Between January 1st, 2012, and November 30th, 2014, 29 consecutive patients with chronic ICSC examined in a referral setting were compared with a gender-matched and age-matched control group of 29 patients. A history of pharmacologic medication (including corticosteroid treatment), sleep disturbance, irregular working hours, cardiovascular risk factors, and depressive anxiety disorders was noted.
RESULTS: The median age of the patients was 52, and in the control subjects it was 50. The male-female ratio for both groups was 4.8:1. Patients with chronic ISCS were more likely to be exposed to irregular working hours (p < 0.01, OR 9.3 [2.29-37.6]) and to present with overweight than the control subjects (p = 0.016). No significant differences were found for sleeping disturbances, pharmacological medication, cardiovascular risk factors, or depressive anxiety disorders.
CONCLUSIONS: In this preliminary study, the exposition of irregular working hours as a risk factor for chronic ICSC was identified, which had not been previously reported. If further studies confirm these findings, then employment with regular working hours could be recommended for chronic ICSC patients.

Entities:  

Keywords:  Central serous chorioretinopathy; Circadian; Overweight; Working hours

Mesh:

Year:  2016        PMID: 27207466     DOI: 10.1007/s00417-016-3378-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  45 in total

1.  When does stress end? Evidence of a prolonged stress reaction in shiftworking truck drivers.

Authors:  Melissa Ara Jo Ulhôa; Elaine Cristina Marqueze; Thomas Kantermann; Debra Skene; Claudia Moreno
Journal:  Chronobiol Int       Date:  2011-11       Impact factor: 2.877

2.  Effects of prior light exposure on early evening performance, subjective sleepiness, and hormonal secretion.

Authors:  Mirjam Münch; Friedrich Linhart; Apiparn Borisuit; Susanne M Jaeggi; Jean-Louis Scartezzini
Journal:  Behav Neurosci       Date:  2011-12-26       Impact factor: 1.912

3.  Might cardiac catheterization influence diurnal rhythm of the steroid stress hormones secretion?

Authors:  H Skarlandtová; M Bičíková; P Neužil; M Mlček; V Hrachovina; T Svoboda; E Medová; J Kudlička; A Dohnalová; S Havránek; H Kazihnítková; L Máčová; E Vařejková; O Kittnar
Journal:  Physiol Res       Date:  2011-12-20       Impact factor: 1.881

4.  Maculopathy a corticosteroid side-effect.

Authors:  I S Jain; K Singh
Journal:  J All India Ophthalmol Soc       Date:  1966-12

5.  Corticosteroid-induced central serous chorioretinopathy.

Authors:  M Wakakura; E Song; S Ishikawa
Journal:  Jpn J Ophthalmol       Date:  1997 May-Jun       Impact factor: 2.447

6.  Central serous chorioretinopathy in younger and older adults.

Authors:  R F Spaide; L Campeas; A Haas; L A Yannuzzi; Y L Fisher; D R Guyer; J S Slakter; J A Sorenson; D A Orlock
Journal:  Ophthalmology       Date:  1996-12       Impact factor: 12.079

7.  Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids.

Authors:  R Haimovici; E S Gragoudas; J S Duker; R N Sjaarda; D Eliott
Journal:  Ophthalmology       Date:  1997-10       Impact factor: 12.079

8.  Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy).

Authors:  Jon E Sprague; Matthew L Banks; Valerie J Cook; Edward M Mills
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

Review 9.  Type-A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Retina       Date:  1987       Impact factor: 4.256

10.  Central serous chorioretinopathy in endogenous hypercortisolism.

Authors:  E A Bouzas; M H Scott; G Mastorakos; G P Chrousos; M I Kaiser-Kupfer
Journal:  Arch Ophthalmol       Date:  1993-09
View more
  5 in total

Review 1.  Fundus Autofluorescence and Clinical Applications.

Authors:  Cameron Pole; Hossein Ameri
Journal:  J Ophthalmic Vis Res       Date:  2021-07-29

2.  CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Alexandre Matet; Suzanne Yzer; Emily Y Chew; Alejandra Daruich; Francine Behar-Cohen; Richard F Spaide
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

3.  Poor Sleep Quality Is the Risk Factor for Central Serous Chorioretinopathy.

Authors:  Yuying Ji; Miaoling Li; Xiongze Zhang; Yuting Peng; Feng Wen
Journal:  J Ophthalmol       Date:  2018-08-01       Impact factor: 1.909

4.  Risk Factors for Persistent or Recurrent Central Serous Chorioretinopathy.

Authors:  Jia Yu; Gezhi Xu; Qing Chang; Xiaofeng Ye; Lei Li; Chunhui Jiang; Qi Zhao
Journal:  J Ophthalmol       Date:  2019-08-14       Impact factor: 1.909

Review 5.  Biomarkers for central serous chorioretinopathy.

Authors:  Gideon Nkrumah; Manuel Paez-Escamilla; Sumit Randhir Singh; Mohammed Abdul Rasheed; Dmitri Maltsev; Abhilash Guduru; Jay Chhablani
Journal:  Ther Adv Ophthalmol       Date:  2020-08-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.